CHICAGO, IL – Shares of healthcare giant Abbott Laboratories (NYSE: ABT) finished Thursday’s session with a modest loss, but a powerful late-day rally that continued after the bell has set a distinctly positive tone for the start of trading next week.
Abbott Labs officially closed the trading day at
0.83 (0.61%). The stock experienced a choppy session, rising to an intraday high of $137.06 before a midday sell-off dragged it to a low of $135.25.
However, the day’s most significant move came in the final hours. In a striking reversal, the stock staged a V-shaped recovery off its lows. This momentum surged into the after-hours market, where shares climbed
136.37, nearly erasing the entire regular session’s decline.
Analysis and Outlook for Monday:
While the official close was negative, the story of the day was the powerful display of buying pressure in the final act. The stock’s sharp rebound from its lows demonstrates that investors aggressively bought the dip, viewing the lower price as an attractive entry point. This is often a sign of underlying strength and positive sentiment.
The strong after-hours performance, which brought the stock almost back to its previous close of $136.45, is a key bullish indicator. Therefore, the outlook for Abbott Laboratories for Monday’s market open is bullish.
Investors should expect the stock to build on this late-day momentum. The market will likely test the recent high of around $137.00 early in the session as the positive sentiment from Thursday’s strong finish carries over into the new week.
